Double Targeted Therapy Approach Could be Key to Curing Nearly All Cancers | Melanoma Dispatch |

Mathematical data gathered at Harvard suggests that using two targeted therapy drugs in a combination therapy could be an effective means of curing almost all types of cancer. The researchers pointed out that monotherapy treatments, in which just one drug is prescribed, work for a while but then begin to fail as the genetic mutations causing the cancer allow it to develop resistance to the drug. They argue that simultaneously prescribing two targeted therapy drugs could cure the cancer before it has a chance to develop resistance, if there is not a time overlap at all between the drugs (a single point mutation in a gene could derail both drugs). This double targeted therapy approach flies in the face of the conventional approach used by oncologists, who prefer to prescribe drugs one at a time.